11. Defining disease modification in myelofibrosis in the era of targeted therapy. Issue 13 (2nd May 2022) Authors: Pemmaraju, Naveen; Verstovsek, Srdan; Mesa, Ruben; Gupta, Vikas; Garcia, Jacqueline S.; Scandura, Joseph M.; Oh, Stephen T.; Passamonti, Francesco; Döhner, Konstanze; Mead, Adam J. Journal: Cancer Issue: Volume 128:Issue 13(2022) Page Start: 2420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition. (25th September 2020) Authors: Padrnos, Leslie; Scherber, Robyn; Geyer, Holly; Langlais, Blake T.; Dueck, Amylou C.; Kosiorek, Heidi E.; Senyak, Zhenya; Clark, Matthew; Boxer, Michael; Cotter, Mary; Harrison, Claire; Stonnington, Cynthia; Geda, Yonas; Mesa, Ruben Journal: Cancer medicine Issue: Volume 9:Number 22(2020) Page Start: 8301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Emerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis. (December 2013) Authors: Gowin, Krisstina; Mesa, Ruben Journal: Expert opinion on investigational drugs Issue: Volume 22:Number 12(2013:Dec.) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Epidemiology of myeloproliferative neoplasms in the United States. Issue 3 (March 2014) Authors: Mehta, Jyotsna; Wang, Hongwei; Iqbal, Sheikh Usman; Mesa, Ruben Journal: Leukemia & lymphoma Issue: Volume 55:Issue 3(2014:Mar.) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera. Issue 6 (11th June 2022) Authors: Tremblay, Douglas; Srisuwananukorn, Andrew; Ronner, Lukas; Podoltsev, Nikolai; Gotlib, Jason; Heaney, Mark L.; Kuykendall, Andrew; O'Connell, Casey L.; Shammo, Jamile M.; Fleischman, Angela; Mesa, Ruben; Yacoub, Abdulraheem; Hoffman, Ronald; Moshier, Erin; Zubizarreta, Nicole; Mascarenhas, John Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Health resource utilization and cost associated with myeloproliferative neoplasms in a large United States health plan. Issue 10 (October 2014) Authors: Mehta, Jyotsna; Wang, Hongwei; Fryzek, Jon P.; Iqbal, Sheikh Usman; Mesa, Ruben Journal: Leukemia & lymphoma Issue: Volume 55:Issue 10(2014:Oct.) Page Start: 2368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. How common are myeloproliferative neoplasms? A systematic review and meta‐analysis. Issue 6 (11th March 2014) Authors: Titmarsh, Glen J.; Duncombe, Andrew S.; McMullin, Mary Frances; O'Rorke, Michael; Mesa, Ruben; De Vocht, Frank; Horan, Sarah; Fritschi, Lin; Clarke, Mike; Anderson, Lesley A. Journal: American journal of hematology Issue: Volume 89:Issue 6(2014:Jun.) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies. Issue 5 (4th September 2020) Authors: Mughal, Tariq I.; Pemmaraju, Naveen; Psaila, Bethan; Radich, Jerald; Bose, Prithviraj; Lion, Thomas; Kiladjian, Jean‐Jacques; Rampal, Raajit; Jain, Tania; Verstovsek, Srdnan; Yacoub, Abdulraheem; Cortes, Jorge E.; Mesa, Ruben; Saglio, Giuseppe; van Etten, Richard A. Journal: Hematological oncology Issue: Volume 38:Issue 5(2020) Page Start: 654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data. (December 2011) Authors: Tibes, Raoul; Mesa, Ruben Journal: Clinical investigation Issue: Volume 1:Number 12(2011) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data. (December 2011) Authors: Tibes, Raoul; Mesa, Ruben Journal: Clinical investigation Issue: Volume 1:Number 12(2011) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗